8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Apr 30, 2026·SEC
Material company update
Mar 16, 2026·SEC
Claritev Corporation(CTEV)Earnings, Financials & Key Ratios
CTEV•NYSE
Price updated Jun 19, 2026
AboutClaritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.Show more
- Revenue$965M+3.7%
- EBITDA$494M+151.8%
- Net Income-$284M+82.7%
- EPS (Diluted)-17.30+83.0%
- Gross Margin27.61%-62.8%
- EBITDA Margin51.12%+149.9%
- Operating Margin4.67%+103.1%
- Net Margin-29.45%+83.3%
CTEV Key Insights
Claritev Corporation (CTEV) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Negative free cash flow
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CTEV posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CTEV Price & Volume
Claritev Corporation (CTEV) stock price & volume — 10-year historical chart
Loading chart...
CTEV Growth Metrics
Claritev Corporation (CTEV) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years0.58%
3 Years-3.66%
TTM5.53%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM75.67%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM76.23%
Return on Capital
10 Years-2.51%
5 Years-4.09%
3 Years-6.81%
Last Year0.94%
CTEV Recent Earnings
Claritev Corporation (CTEV) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/8 qtrs (38%)●Beat Revenue 5/8 qtrs (71%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$4.41-15.7%
$3.81
Rev
$245M+3.5%
$236M
Q1 2026
Feb 23, 2026Metric
Actual
Est
EPS
$4.88-674.1%
$0.85
Rev
$247M+2.2%
$241M
Q4 2025
Nov 7, 2025Metric
Actual
Est
EPS
$4.07-30.4%
$3.12
Rev
$246M+2.0%
$241M
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$0.32+111.9%
$2.69
Rev
$242M+4.1%
$232M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $4.41vs $3.81-15.7% | $245Mvs $236M+3.5% |
| Q1 2026 | Feb 23, 2026 | $4.88vs $0.85-674.1% | $247Mvs $241M+2.2% |
| Q4 2025 | Nov 7, 2025 | $4.07vs $3.12-30.4% | $246Mvs $241M+2.0% |
| Q3 2025 | Aug 6, 2025 | $0.32vs $2.69+111.9% | $242Mvs $232M+4.1% |
Based on last 8 quarters of dataView full earnings history →
CTEV Peer Comparison
Claritev Corporation (CTEV) competitors in Payer and Benefits Administration — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 EHTH | 51.27M | 1.65 | -4.85 | 4.06% | 6.31% | 3.99% | 0.14 | |
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 | |
 TDOC | 1.46B | 8.07 | -7.08 | -1.54% | -6.81% | -12.37% | 0.75 | |
 EXLS | 4.06B | 25.93 | 16.84 | 13.56% | 11.66% | 27.16% | 0.44 | |
 PGNY | 2.04B | 26.08 | 40.12 | 10.4% | 5.23% | 13.34% | 0.05 | |
 UNH | 363.94B | 400.96 | 30.31 | 11.81% | 2.68% | 11.54% | 0.77 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 | |
 CI | 73.63B | 279.27 | 12.60 | 11.26% | 2.26% | 15.08% | 0.75 |
Compare CTEV vs Peers
Claritev Corporation (CTEV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CTEV Income Statement
Claritev Corporation (CTEV) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 982.9M | 937.76M | 1.12B | 1.08B | 961.52M | 930.62M | 965.41M | 978.76M |
Revenue Growth % | - | -4.59% | 19.18% | -3.39% | -10.95% | -3.21% | 3.74% | 5.53% |
Cost of Goods Sold | 149.61M | 318.68M | 175.29M | 204.1M | 235.47M | 239.4M | 698.84M | 381.09M |
COGS % of Revenue | 15.22% | 33.98% | 15.68% | 18.9% | 24.49% | 25.73% | 72.39% | - |
Gross Profit | 833.29M▲ 0% | 619.09M▼ 25.7% | 942.31M▲ 52.2% | 875.62M▼ 7.1% | 726.06M▼ 17.1% | 691.22M▼ 4.8% | 266.58M▼ 61.4% | 597.67M▲ 0% |
Gross Margin % | 84.78% | 66.02% | 84.32% | 81.1% | 75.51% | 74.27% | 27.61% | 61.06% |
Gross Profit Growth % | - | -25.71% | 52.21% | -7.08% | -17.08% | -4.8% | -61.43% | - |
Operating Expenses | 465.08M | 750.91M | 556.19M | 1.24B | 564.07M | 2.08B | 221.52M | 555.68M |
OpEx % of Revenue | 47.32% | 80.07% | 49.77% | 114.69% | 58.66% | 223.63% | 22.95% | - |
Selling, General & Admin | 75.22M | 355.63M | 151.09M | 132.14M | 135.99M | 160.22M | 221.52M | 206.89M |
SG&A % of Revenue | 7.65% | 37.92% | 13.52% | 12.24% | 14.14% | 17.22% | 22.95% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - |
Other Operating Expenses | 389.86M | 395.27M | 405.1M | 1.11B | 428.08M | 1.92B | 0 | 3M |
Operating Income | 368.21M▲ 0% | -131.82M▼ 135.8% | 386.12M▲ 392.9% | -362.73M▼ 193.9% | 161.98M▲ 144.7% | -1.39B▼ 958.1% | 45.06M▲ 103.2% | 41.99M▲ 0% |
Operating Margin % | 37.46% | -14.06% | 34.55% | -33.6% | 16.85% | -149.35% | 4.67% | 4.29% |
Operating Income Growth % | - | -135.8% | 392.91% | -193.94% | 144.66% | -958.08% | 103.24% | - |
EBITDA | 767.66M | 271.86M | 798.18M | 52.93M | 587.77M | -953.49M | 493.51M | 489.88M |
EBITDA Margin % | 78.1% | 28.99% | 71.42% | 4.9% | 61.13% | -102.46% | 51.12% | 50.05% |
EBITDA Growth % | - | -64.59% | 193.6% | -93.37% | 1010.53% | -262.22% | 151.76% | 207.9% |
D&A (Non-Cash Add-back) | 399.45M | 403.68M | 412.06M | 415.66M | 425.79M | 436.44M | 448.45M | 447.88M |
EBIT | 386.86M | -211.27M | 402.93M | -257.34M | 226.15M | -1.44B | 26.99M | 71.07M |
Net Interest Income | -376.15M | -335.35M | -267.44M | -299.9M | -324.98M | -323.24M | -398.51M | -397.03M |
Interest Income | 196K | 288K | 30K | 3.5M | 8.23M | 3.13M | 1.56M | 1.25M |
Interest Expense | 376.35M | 335.64M | 267.48M | 303.4M | 333.21M | 326.37M | 400.07M | 398.28M |
Other Income/Expense | -357.7M | -415.09M | -250.67M | -198.01M | -269.04M | -380.78M | -418.14M | -370.71M |
Pretax Income | 10.51M▲ 0% | -546.91M▼ 5304.2% | 135.45M▲ 124.8% | -560.74M▼ 514.0% | -107.06M▲ 80.9% | -1.77B▼ 1553.9% | -373.08M▲ 78.9% | -328.71M▲ 0% |
Pretax Margin % | 1.07% | -58.32% | 12.12% | -51.93% | -11.13% | -190.27% | -38.64% | -33.58% |
Income Tax | 799K | -26.34M | 33.37M | 12.17M | -15.36M | -124.88M | -88.8M | -42.19M |
Effective Tax Rate % | 7.6% | 4.82% | 24.64% | -2.17% | 14.35% | 7.05% | 23.8% | 12.84% |
Net Income | 9.71M▲ 0% | -520.56M▼ 5461.1% | 102.08M▲ 119.6% | -572.91M▼ 661.2% | -91.7M▲ 84.0% | -1.65B▼ 1694.9% | -284.28M▲ 82.7% | -286.52M▲ 0% |
Net Margin % | 0.99% | -55.51% | 9.13% | -53.06% | -9.54% | -176.85% | -29.45% | -29.27% |
Net Income Growth % | - | -5461.11% | 119.61% | -661.24% | 83.99% | -1694.86% | 82.73% | 75.67% |
Net Income (Continuing) | 9.71M | -520.56M | 102.08M | -572.91M | -91.7M | -1.65B | -284.28M | -286.52M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 6.72M | 6.72M |
EPS (Diluted) | 0.35▲ 0% | -44.23▼ 12737.1% | 6.40▲ 114.5% | -35.87▼ 660.5% | -5.69▲ 84.1% | -101.92▼ 1691.2% | -17.30▲ 83.0% | -17.16▲ 0% |
EPS Growth % | - | -12737.14% | 114.47% | -660.47% | 84.14% | -1691.21% | 83.03% | 76.23% |
EPS (Basic) | 0.35 | -44.23 | 6.40 | -35.87 | -5.69 | -101.92 | -17.30 | - |
Diluted Shares Outstanding | 27.5M | 11.77M | 16.29M | 15.97M | 16.13M | 16.15M | 16.43M | 16.69M |
Basic Shares Outstanding | 27.5M | 11.77M | 16.28M | 15.97M | 16.13M | 16.15M | 16.43M | 16.69M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
CTEV Balance Sheet
Claritev Corporation (CTEV) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 115.61M | 208.85M | 319.26M | 446.74M | 193.59M | 175.51M | 224.37M | 242.27M |
Cash & Short-Term Investments | 21.82M | 126.75M | 185.33M | 334.05M | 71.55M | 16.85M | 16.81M | 21.33M |
Cash Only | 21.82M | 126.75M | 185.33M | 334.05M | 71.55M | 16.85M | 16.81M | 21.33M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 77.07M | 63.2M | 99.91M | 78.91M | 84.75M | 111.61M | 138.18M | 140.92M |
Days Sales Outstanding | 28.62 | 24.6 | 32.63 | 26.67 | 32.17 | 43.77 | 52.24 | 52.58 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - |
Other Current Assets | 195K | 1.19M | 4.05M | 10.19M | 12.49M | 19.82M | 69.38M | 80.02M |
Total Non-Current Assets | 8.24B | 8.07B | 7.9B | 6.92B | 6.77B | 4.98B | 4.66B | 4.6B |
Property, Plant & Equipment | 207.99M | 218.97M | 243.34M | 257.07M | 287.11M | 308.75M | 340.29M | 357.15M |
Fixed Asset Turnover | 4.73x | 4.28x | 4.59x | 4.20x | 3.35x | 3.01x | 2.84x | 2.90x |
Goodwill | 4.14B | 4.26B | 4.36B | 3.71B | 3.83B | 2.4B | 2.41B | 2.41B |
Intangible Assets | 3.89B | 3.58B | 3.29B | 2.94B | 2.63B | 2.23B | 1.88B | 1.8B |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 15M | 0 | 0 |
Other Non-Current Assets | 8.15M | 14.23M | 9.7M | 21.89M | 21.78M | 22.1M | 33.34M | 35.34M |
Total Assets | 8.36B▲ 0% | 8.28B▼ 0.9% | 8.22B▼ 0.8% | 7.37B▼ 10.3% | 6.96B▼ 5.5% | 5.15B▼ 26.0% | 4.89B▼ 5.1% | 4.84B▲ 0% |
Asset Turnover | 0.12x | 0.11x | 0.14x | 0.15x | 0.14x | 0.18x | 0.20x | 0.20x |
Asset Growth % | - | -0.92% | -0.76% | -10.33% | -5.51% | -26.04% | -5.09% | -27.77% |
Total Current Liabilities | 85.79M | 112.5M | 141.91M | 175.84M | 166.74M | 213.79M | 261.36M | 189.56M |
Accounts Payable | 9.56M | 15.26M | 13.01M | 13.29M | 19.59M | 86.33M | 60.46M | 59.18M |
Days Payables Outstanding | 23.34 | 17.48 | 27.08 | 23.78 | 30.37 | 131.62 | 31.58 | 48.37 |
Short-Term Debt | 0 | 0 | 13.25M | 13.25M | 13.25M | 13.25M | 19.39M | 19.6M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 26.31M | 21.84M | 25.42M | 34.57M | 44.72M | 33.69M | 181.5M | 110.79M |
Current Ratio | 1.35x | 1.86x | 2.25x | 2.54x | 1.16x | 0.82x | 0.86x | 1.28x |
Quick Ratio | 1.35x | 1.86x | 2.25x | 2.54x | 1.16x | 0.82x | 0.86x | 1.28x |
Cash Conversion Cycle | - | - | - | - | - | - | - | 4.22 |
Total Non-Current Liabilities | 6.29B | 5.61B | 5.73B | 5.4B | 5.09B | 4.85B | 4.79B | 4.88B |
Long-Term Debt | 5.4B | 4.58B | 4.88B | 4.74B | 4.53B | 4.51B | 4.6B | 4.59B |
Capital Lease Obligations | 23.19M | 27.59M | 26.73M | 20.89M | 17.12M | 13.86M | 16.24M | 49.76M |
Deferred Tax Liabilities | 869.2M | 900.63M | 753.83M | 639.5M | 521.71M | 325.83M | 197.6M | 839.22M |
Other Non-Current Liabilities | 0 | 106.59M | 74.14M | 2.47M | 17.26M | 3.6M | -16.24M | 125M |
Total Liabilities | 6.38B | 5.73B | 5.88B | 5.58B | 5.26B | 5.07B | 5.06B | 5.07B |
Total Debt | 5.43B | 4.61B | 4.93B | 4.78B | 4.57B | 4.54B | 4.63B | 4.61B |
Net Debt | 5.41B | 4.49B | 4.74B | 4.45B | 4.5B | 4.52B | 4.62B | 4.59B |
Debt / Equity | 2.74x | 1.80x | 2.10x | 2.67x | 2.67x | 54.05x | - | -19.66x |
Debt / EBITDA | 7.07x | 16.97x | 6.17x | 90.36x | 7.77x | - | 9.39x | 9.41x |
Net Debt / EBITDA | 7.04x | 16.50x | 5.94x | 84.05x | 7.65x | - | 9.35x | 9.36x |
Interest Coverage | 1.03x | -0.63x | 1.51x | -0.85x | 0.68x | -4.43x | 0.07x | 0.18x |
Total Equity | 1.99B▲ 0% | 2.56B▲ 28.8% | 2.34B▼ 8.3% | 1.79B▼ 23.6% | 1.71B▼ 4.5% | 84.02M▼ 95.1% | -167.18M▼ 299.0% | -234.41M▲ 0% |
Equity Growth % | - | 28.85% | -8.33% | -23.63% | -4.55% | -95.08% | -298.97% | -2235.85% |
Book Value per Share | 72.19 | 217.33 | 143.95 | 112.10 | 105.97 | 5.20 | -10.17 | -14.04 |
Total Shareholders' Equity | 1.99B | 2.56B | 2.34B | 1.79B | 1.71B | 84.02M | -173.9M | -241.14M |
Common Stock | 42K | 66K | 67K | 67K | 2K | 2K | 2K | 2K |
Retained Earnings | 637.56M | 117M | 225.11M | -347.8M | -499.31M | -2.15B | -2.43B | -2.5B |
Treasury Stock | 0 | -89.61M | -192.17M | -192.17M | -128.36M | -138.73M | -138.73M | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | -11.78M | -5.06M | -4.17M | -2.35M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 6.72M | 6.72M |
CTEV Cash Flow Statement
Claritev Corporation (CTEV) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | 284.31M | 377.37M | 404.69M | 372.36M | 171.72M | 107.62M | 117.32M | 98.74M |
Operating CF Margin % | 28.93% | 40.24% | 36.21% | 34.49% | 17.86% | 11.56% | 12.15% | - |
Operating CF Growth % | - | 32.73% | 7.24% | -7.99% | -53.88% | -37.33% | 9.02% | 391.76% |
Net Income | 9.71M | -520.56M | 102.08M | -572.91M | -91.7M | -1.65B | -284.28M | -286.52M |
Depreciation & Amortization | 399.45M | 403.68M | 424.32M | 415.66M | 425.79M | 436.44M | 445.43M | 223.38M |
Stock-Based Compensation | -14.88M | 406.05M | 18.01M | 16.74M | 18.02M | 26.64M | 27.82M | 7.8M |
Deferred Taxes | -111.4M | -45.04M | 0 | -114.38M | -114.06M | -198.01M | -128.51M | -76.94M |
Other Non-Cash Items | -4.92M | 103.23M | -93.04M | 571.92M | -44.42M | 1.5B | 85.73M | 229.08M |
Working Capital Changes | 6.35M | 30.01M | -46.68M | 55.34M | -21.91M | -13.67M | -28.87M | 1.95M |
Change in Receivables | 5.28M | 14.76M | -33.83M | 21M | 4.4M | -13.2M | -26.57M | -35.49M |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 20.78M | 29.07M | 0 | 0 | 0 | 42.22M | -25.86M | 87.09M |
Cash from Investing | -66.41M | -210.84M | -228.38M | -104.45M | -249.79M | -118.12M | -121.02M | -128.92M |
Capital Expenditures | -66.41M | -70.81M | -84.59M | -89.73M | -108.85M | -118.12M | -129.6M | -137.5M |
CapEx % of Revenue | 6.76% | 7.55% | 7.57% | 8.31% | 11.32% | 12.69% | 13.42% | 14.05% |
Acquisitions | 0 | -140.03M | -149.43M | 0 | -140.94M | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 5.64M | 0 | 0 | 0 | -7.42M | 8.58M |
Cash from Financing | -201.09M | -61.6M | -114.68M | -115.74M | -180.99M | -41.31M | 2.36M | 31M |
Debt Issued (Net) | -201.09M | 2.2B | -10.89M | -13.28M | -165.82M | -28.07M | 4.72M | 39.72M |
Equity Issued (Net) | 0 | -101.12M | -103.79M | -100M | -14.71M | -10.37M | 1.74M | 1.26M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -101.12M | -103.79M | -100M | -15.22M | -10.37M | 0 | 0 |
Other Financing | 0 | -2.16B | 0 | -2.46M | -465K | -2.88M | -4.09M | -9.97M |
Net Change in Cash | 16.81M▲ 0% | 104.93M▲ 524.2% | 61.62M▼ 41.3% | 152.18M▲ 146.9% | -259.06M▼ 270.2% | -51.82M▲ 80.0% | -1.33M▲ 97.4% | 828K▲ 0% |
Free Cash Flow | 217.9M▲ 0% | 306.56M▲ 40.7% | 320.1M▲ 4.4% | 282.63M▼ 11.7% | 62.87M▼ 77.8% | -10.51M▼ 116.7% | -12.28M▼ 16.8% | -38.76M▲ 0% |
FCF Margin % | 22.17% | 32.69% | 28.64% | 26.18% | 6.54% | -1.13% | -1.27% | -3.96% |
FCF Growth % | - | 40.69% | 4.42% | -11.71% | -77.76% | -116.71% | -16.85% | 60.93% |
FCF per Share | 7.92 | 26.05 | 19.65 | 17.69 | 3.90 | -0.65 | -0.75 | -2.32 |
FCF Conversion (FCF/Net Income) | 29.28x | -0.72x | 3.96x | -0.65x | -1.87x | -0.07x | -0.41x | 0.14x |
Interest Paid | 363.91M | 312.35M | 231.05M | 0 | 0 | 315.25M | 0 | 35.51M |
Taxes Paid | 114.57M | 3.92M | 0 | 0 | 0 | 80.09M | 0 | 41.45M |
CTEV Key Ratios
Claritev Corporation (CTEV) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -22.92% | 4.16% | -27.71% | -5.24% | -183.57% | - | 210.94% |
Return on Invested Capital (ROIC) | -1.37% | 4.1% | -4.08% | 1.95% | -19.28% | 0.75% | 0.71% |
Gross Margin | 66.02% | 84.32% | 81.1% | 75.51% | 74.27% | 27.61% | 61.06% |
Net Margin | -55.51% | 9.13% | -53.06% | -9.54% | -176.85% | -29.45% | -29.27% |
Debt / Equity | 1.80x | 2.10x | 2.67x | 2.67x | 54.05x | - | -19.66x |
Interest Coverage | -0.63x | 1.51x | -0.85x | 0.68x | -4.43x | 0.07x | 0.18x |
FCF Conversion | -0.72x | 3.96x | -0.65x | -1.87x | -0.07x | -0.41x | 0.14x |
Revenue Growth | -4.59% | 19.18% | -3.39% | -10.95% | -3.21% | 3.74% | 5.53% |
Related:CTEV Dividend History·CTEV Revenue History·CTEV Price History·CTEV P/E History·CTEV Financial Ratios·CTEV Institutional Holders
CTEV SEC Filings & Documents
Claritev Corporation (CTEV) SEC filings — annual & quarterly reports (10-K, 10-Q)
CTEV Frequently Asked Questions
Claritev Corporation (CTEV) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Claritev Corporation (CTEV) reported $978.8M in revenue for fiscal year 2025. This represents a 0% decrease from $982.9M in 2019.
Claritev Corporation (CTEV) grew revenue by 3.7% over the past year. Growth has been modest.
Claritev Corporation (CTEV) reported a net loss of $286.5M for fiscal year 2025.
Dividend & Returns
Claritev Corporation (CTEV) had negative free cash flow of $38.8M in fiscal year 2025, likely due to heavy capital investments.